Search

everythinglearnresearchcommunity

for

Search:↓

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Blocking YAP/TAZ could be a new way to treat skin cancer.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Semaglutide does not significantly increase the risk of hair loss.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Eating barley for life may lead to healthier aging in mice.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Pranlukast and mirabegron may work as new diabetes drugs.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

OR2AT4 helps reduce aging and cell damage in human skin cells.

Androgens and other hormones affect hair growth and skin conditions like acne.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Somatostatin may help protect hair follicles from immune attacks.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

New drugs for heart disease may be developed from molecules secreted by stem cells.